Daniel Z Lieberman
Healthcare Services · United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
United StatesWebsite
www.danielzlieberman.comRevenue
<$5 MillionIndustry
About Daniel Z Lieberman
Is Daniel Z Lieberman your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Daniel Z Lieberman, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Daniel Z Lieberman has new funding data
Check if Daniel Z Lieberman has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Daniel Z Lieberman launches new products
Check out if Daniel Z Lieberman is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Daniel Z Lieberman recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Daniel Z Lieberman
Website visits: Recent activity has been detected on your website
Click to see if Daniel Z Lieberman had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at Daniel Z Lieberman
Find more new buyers
Compare Similar Companies to Daniel Z Lieberman
Compare insights from companies similar to Daniel Z Lieberman, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Daniel Z Lieberman
Daniel Z Lieberman Tech Stack
Top Healthcare Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Daniel Z Lieberman
Dr. Daniel Lieberman is a psychiatrist located in the Washington, DC area, specializing in the exploration of the unconscious mind and its profound effects on human behavior. He is the author of notable works such as 'Spellbound: Modern Science, Ancient Magic, and the Hidden Potential of the Unconscious Mind' and 'The Molecule of More', the latter... Read More